Total Payments
$2,698
2024 Payments
$2,657
Companies
34
Transactions
88
Medicare Patients
6,090
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$2,523 (93.5%)
Education$174.94 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,523 | 86 | 93.5% |
| Education | $174.94 | 2 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $364.10 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $263.51 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $257.32 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $195.15 | 7 | $0 (2024) |
| Aveo Pharmaceuticals, Inc. | $130.78 | 3 | $0 (2024) |
| Stemline Therapeutics Inc. | $121.55 | 1 | $0 (2024) |
| Incyte Corporation | $110.99 | 5 | $0 (2024) |
| PFIZER INC. | $106.11 | 4 | $0 (2024) |
| ABBVIE INC. | $105.04 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $99.95 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,657 | 86 | E.R. Squibb & Sons, L.L.C. ($364.10) |
| 2021 | $41.25 | 2 | Genentech USA, Inc. ($22.05) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Oncology | ||||||
| 12/11/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $121.83 | General |
| Category: Hematology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Itovebi (Biological), Polivy, Tecentriq Hybreza | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: BioOncology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Oncology | ||||||
| 11/26/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.72 | General |
| 11/22/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Oncology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $30.56 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.40 | General |
| 10/22/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Oncology | ||||||
| 10/18/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $46.35 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/11/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $40.62 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $30.60 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,168 | 19,939 | $1.7M | $415,564 |
| 2022 | 23 | 2,087 | 60,951 | $3.8M | $801,455 |
| 2021 | 18 | 1,952 | 71,070 | $4.6M | $837,671 |
| 2020 | 19 | 883 | 21,261 | $1.1M | $213,770 |
Total Patients
6,090
Total Services
173,221
Medicare Billing
$2.3M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1955 | Injection, levocarnitine, per 1 gm | Office | 2023 | 87 | 3,698 | $252,315 | $94,254 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 928 | $194,262 | $66,622 | 34.3% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 53 | 1,572 | $393,000 | $56,044 | 14.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 95 | 3,734 | $205,370 | $43,688 | 21.3% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 126 | 1,541 | $115,575 | $42,415 | 36.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 121 | 797 | $82,705 | $36,684 | 44.4% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2023 | 63 | 2,681 | $128,571 | $23,321 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 146 | $33,490 | $14,444 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $17,702 | $7,725 | 43.6% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 43 | 368 | $27,600 | $7,508 | 27.2% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2023 | 87 | 3,669 | $181,181 | $7,232 | 4.0% |
| 95905 | Nerve conduction study of arm or leg movement and/or feeling with review and report | Office | 2023 | 51 | 119 | $11,148 | $3,717 | 33.3% |
| 97016 | Application of blood vessel compression device | Office | 2023 | 66 | 533 | $18,655 | $3,715 | 19.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 27 | 27 | $11,009 | $2,490 | 22.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $5,051 | $2,248 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $4,473 | $1,909 | 42.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $2,340 | $1,318 | 56.3% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 13 | 27 | $732.78 | $232.53 | 31.7% |
| J1955 | Injection, levocarnitine, per 1 gm | Office | 2022 | 140 | 12,964 | $884,534 | $241,205 | 27.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 154 | 13,067 | $718,740 | $152,044 | 21.2% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 141 | 3,304 | $247,800 | $89,194 | 36.0% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2022 | 140 | 12,909 | $627,235 | $87,718 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 977 | $242,966 | $70,375 | 29.0% |
| J3411 | Injection, thiamine hcl, 100 mg | Office | 2022 | 140 | 12,909 | $673,761 | $27,066 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 272 | $58,088 | $26,996 | 46.5% |
About Janet Hall, NP
Janet Hall, NP is a Nurse Practitioner healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1538390687.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janet Hall, NP has received a total of $2,698 in payments from pharmaceutical and medical device companies, with $2,657 received in 2024. These payments were reported across 88 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,523).
As a Medicare-enrolled provider, Hall has provided services to 6,090 Medicare beneficiaries, totaling 173,221 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Palo Alto, CA
- Active Since 08/06/2009
- Last Updated 03/14/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1538390687
Products in Payments
- KEYTRUDA (Biological) $257.32
- OPDIVO (Biological) $242.27
- FOTIVDA (Drug) $130.78
- REBLOZYL (Biological) $121.83
- Orserdu (Drug) $121.55
- IMFINZI (Biological) $108.72
- MONJUVI (Drug) $94.66
- ENHERTU (Biological) $83.33
- IMBRUVICA (Drug) $77.66
- CALQUENCE (Drug) $71.46
- VONJO (Drug) $66.00
- Udenyca (Biological) $60.99
- Fabhalta (Drug) $59.74
- OJJAARA (Drug) $57.20
- Epkinly (Drug) $55.96
- SCEMBLIX (Drug) $53.52
- PLUVICTO (Drug) $51.18
- SARCLISA (Biological) $48.82
- Lenvima (Drug) $46.91
- AYVAKIT (Drug) $46.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Palo Alto
Judith Lea, Np, NP
Nurse Practitioner — Payments: $7,480
Nurse Practitioner $7,480
Rachael Small, Arnp, ARNP
Nurse Practitioner — Payments: $5,050
Nurse Practitioner $5,050
Mrs. Megan Larsen, Crnp, CRNP
Nurse Practitioner — Payments: $4,639
Nurse Practitioner $4,639
Melissa Martz, Np, NP
Nurse Practitioner — Payments: $4,033
Nurse Practitioner $4,033
Fariba Hajy Iseyedsoleiman
Nurse Practitioner — Payments: $3,753
Nurse Practitioner $3,753
Amy Murphy, N.p, N.P
Nurse Practitioner — Payments: $2,334
Nurse Practitioner $2,334